Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/454,436external-prioritypatent/US6258793B1/en
Priority claimed from EP99124456Aexternal-prioritypatent/EP1106604A1/en
Application filed by Sanofi Aventis DeutschlandfiledCriticalSanofi Aventis Deutschland
Publication of AR026715A1publicationCriticalpatent/AR026715A1/en
Preparation Of Compounds By Using Micro-Organisms
(AREA)
Abstract
La Amicomicina, un proceso para su produccion y su uso como producto farmacéutico. Un compuesto llamado Amicomicina, de la siguiente formula 1 y sus salesy derivados farmacéuticamente aceptables, en todas sus formas estereoisomeras y tautomeras, pued e ser obtenido por medio del cultivo del microorganismoAmicolaptosis sp ST101170 (DSM 12216) y encuentra una utilizacion como producto faramcéutico, en particular como antibiotico.Amicomycin, a process for its production and its use as a pharmaceutical product. A compound called Amicomycin, of the following formula 1 and its pharmaceutically acceptable salts and derivatives, in all its stereoisomere and tautomere forms, can be obtained through the cultivation of the microorganism Amicolaptosis sp ST101170 (DSM 12216) and finds a use as a pharmaceutical product, in Particular as an antibiotic.
ARP000106419A1999-12-032000-12-04
AMICOMYCIN, A PROCESS FOR ITS PRODUCTION AND ITS USE AS A PHARMACEUTICAL PRODUCT.
AR026715A1
(en)
N-Phenpropylcyclopentyl-Substituted Glutaramide Derivatives as Inhibitors of Neutral Endopeptidase Enzyme (NEP) for Treating Female Sexual Dysfunction (FSAD)